Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 29:11:632834.
doi: 10.3389/fonc.2021.632834. eCollection 2021.

Biomarkers (mRNAs and Non-Coding RNAs) for the Diagnosis and Prognosis of Colorectal Cancer - From the Body Fluid to Tissue Level

Jinhua He  1 , Feifeng Wu  2 , Zeping Han  1 , Min Hu  2 , Weida Lin  2 , Yuguang Li  1 , Mingrong Cao  2
Affiliations
Review

Biomarkers (mRNAs and Non-Coding RNAs) for the Diagnosis and Prognosis of Colorectal Cancer - From the Body Fluid to Tissue Level

Jinhua He et al. Front Oncol. .

Erratum in

Abstract

In recent years, the diagnosis and treatment of colorectal cancer (CRC) have been continuously improved, but the mortality rate continues to be high, especially in advanced patients. CRC patients usually have no obvious symptoms in the early stage and are already in the advanced stage when they are diagnosed. The 5-year survival rate is only 10%. The blood markers currently used to screen for CRC, such as carcinoembryonic antigen and carbohydrate antigen 19-9, have low sensitivity and specificity, whereas other methods are invasive or too expensive. As a result, recent research has shifted to the development of minimally invasive or noninvasive biomarkers in the form of body fluid biopsies. Non-coding RNA molecules are composed of microRNAs, long non-coding RNAs, small nucleolar RNAs, and circular RNAs, which have important roles in the occurrence and development of diseases and can be utilized for the early diagnosis and prognosis of tumors. In this review, we focus on the latest findings of mRNA-ncRNA as biomarkers for the diagnosis and prognosis of CRC, from fluid to tissue level.

Keywords: biomarkers; colorectal cancer; diagnosis; mRNA; ncRNA; prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of colorectal cancer.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin (2018) 68(6):394–424. doi: 10.3322/caac.21492 - DOI - PubMed
    1. Coppede F, Lopomo A, Spisni R, Migliore L. Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Colorectal Cancer. World J Gastroenterol (2014) 20(4):943–56. doi: 10.3748/wjg.v20.i4.943 - DOI - PMC - PubMed
    1. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and Patterns of Recurrence After Resection for Cure of Colonic Cancer in a Well Defined Population. Br J Surg (2006) 93(9):1115–22. doi: 10.1002/bjs.5349 - DOI - PubMed
    1. Langan RC, Mullinax JE, Raiji MT, Upham T, Summers T, Stojadinovic A, et al. . Colorectal Cancer Biomarkers and the Potential Role of Cancer Stem Cells. J Cancer (2013) 4(3):241–50. doi: 10.7150/jca.5832 - DOI - PMC - PubMed
    1. Lech G, Slotwinski R, Slodkowski M, Krasnodebski IW. Colorectal Cancer Tumour Markers and Biomarkers: Recent Therapeutic Advances. World J Gastroenterol (2016) 22(5):1745–55. doi: 10.3748/wjg.v22.i5.1745 - DOI - PMC - PubMed